as informed in voanews
Experimental Zika Vaccine Protects Monkeys
Experimental Zika Vaccine Protects Monkeys
Researchers are getting closer to a vaccine against Zika virus, which causes severe birth defects in the babies of women who become infected while pregnant.The experimental Zika vaccine being worked on by researchers at the National Institutes of Health is a newer generation of vaccine, which uses DNA technology to trigger the body's immune response.That is a different approach than traditional vaccines take.
in the same way dailycaller
Zika Vaccine Works In Monkeys
Zika Vaccine Works In Monkeys
5240727An experimental DNA-based vaccine is proceeding to human trials after it successfully protected monkeys from the Zika virus.The vaccine caused the primates to develop Zika antibodies.Based on these findings, scientists can begin clinical safety trials in healthy humans.
in the same way ndtv
Sanofi Gets $43 Million US Funding To Spur Zika Vaccine Development â€" NDTV Profit
Sanofi Gets $43 Million US Funding To Spur Zika Vaccine Development â€" NDTV Profit
Sanofi SA said on Monday the US Department of Health and Human Services (HHS) approved $43.18 million in funding to accelerate the development of a Zika vaccine, as efforts to prevent the infection gather momentum.The funding from the HHS' Biomedical Advanced Research and Development Authority (BARDA) will be used for mid-stage trials, expected to begin in the first half of 2018, and for manufacturing, the French drug maker said.The contract runs through June 2022, but if the data is positive, the contract includes an option for up to additional $130.45 million for late-stage trials necessary for eventual approval.Work on the vaccine began in March as a collaborative effort between the US Department Of Defense's Walter Reed Army Institute of Research (WRAIR), BARDA and the National Institutes of Health.Sanofi in July teamed up with WRAIR to co-develop the vaccine.Earlier this month, BARDA gave Japanese drug maker Takeda Pharmaceutical Co nearly $20 million in initial funding to develop a Zika vaccine.Sanofi is one of the many companies around the world looking to develop a vaccine against the virus that has spread rapidly since the current outbreak was first detected last year in Brazil.Hundreds of thousands of people are estimated to have been infected with Zika in the Americas and parts of Asia.
No comments:
Post a Comment